HVT Medical

Company Overview

Snapshot

Founded in January 2022, HVT Medical operates with 1–10 employees. The company has raised $1.5 million across two funding rounds. In January 2024, HVT Medical secured a grant from the Israel Innovation Authority.

Business overview

HVT Medical is a Health Tech & Life Sciences company focused on developing innovative solutions for patients contraindicated for aortic valve implantation due to anatomical limitations. The company's core product, The Splitter, is a device designed to modify the aortic valve through a catheterization procedure, enabling safe transcatheter valve implantation (TAVI). This device performs cusp splitting prior to TAVI to mitigate the risk of coronary occlusion, utilizing an advanced catheter with a cutting head that mimics an alligator jaw. HVT Medical serves the healthcare and medical devices industries, specifically targeting cardiology and hospitals with its medical treatment and therapeutics technology.

Company Intelligence Q&A

What is HVT Medical's primary focus?

HVT Medical focuses on developing solutions for patients contraindicated for aortic valve implantation due to anatomical limitations, specifically in the cardiology and medical device sectors.

When was HVT Medical founded?

HVT Medical was founded in January 2022.

What is The Splitter device?

The Splitter is a device developed by HVT Medical that can be inserted in a catheterization procedure to modify the aortic valve. It performs cusp splitting before a TAVI procedure to reduce the risk of coronary occlusion by creating an intentional laceration or excision of the valve's cusp tissue using an advanced catheter with a cutting head.

How much capital has HVT Medical raised?

HVT Medical has raised $1.5 million across two funding rounds.

Did HVT Medical receive any grants?

In January 2024, HVT Medical secured a grant from the Israel Innovation Authority.